Navigation Links
MGT Chairman and CEO Buys 250,000 MGT shares

NEW YORK, Oct. 8 /PRNewswire-FirstCall/ -- MGT Capital Investments, Inc. (Amex: MGT), a holding company focused on the Healthcare Information Technology ("HCIT") sector, today announced that the Company's Chairman and CEO, Tim Paterson-Brown, has acquired 250,000 shares of MGT common stock from an existing shareholder in a single private transaction at $3.75 per share, for $937,500.

Tim Paterson-Brown, Chairman and CEO, stated, "It has been my belief for some time now that the value of MGT's current holdings in its subsidiaries is not accurately reflected in the current share price. Consequently, I have chosen to increase my personal investment in MGT over the past two years in an effort to take advantage of this valuation gap."

"In addition, I believe that our Medicsight subsidiary has tremendous potential for future growth. We recently announced the positive results of the ACRIN Study, endorsing the use of virtual colonoscopy, and we believe that as a result of this study, Medicsight's virtual colonoscopy technology will see increased future demand."

About MGT Capital Investments, Inc.

MGT Capital Investments, Inc is a holding company that focuses on investments in the global healthcare information technology market. We have two subsidiaries, Medicsight PLC and Medicexchange PLC. Medicsight PLC is a medical imaging software development company developing enterprise-wide Computer-Aided Detection (CAD) software which analyzes computer tomography (CT) scans for the early detection and measurement of colorectal polyps and lung lesions. Medicsight has focused on two of the leading causes of cancer- related death, colorectal cancer and lung cancer. Medicexchange PLC provides medical imaging professionals with a global web portal containing an online sales, jobs and information channel for diagnostic, treatment and surgery planning solutions. This combined with a variety of relevant clinical papers, training materials and content gives these professionals access to information and products that they otherwise would have difficulty accessing. Additional information can be found at

All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward- looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.

For further information: Media enquiries:

MGT Capital Investments KCSA Worldwide

Alex van Klaveren Todd Fromer / Garth Russell

Tel: +1 646-257-2644 Tel: +1 212-896-1215 / 212-896-1250 /

SOURCE MGT Capital Investments, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
2. Shares Of AVI BioPharma Drops On Reports Of Disappointing Early Drug Trail
3. Learn From a Leader: Smitherman shares a personal story about his battle with drugs
4. Sun Pharma Allots Shares Upon Fccbs Conversion
5. Zenotech Issues 20 Lakh Shares to Ranbaxy for Rs 20 Cr
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... transport experience for the millions of people who require these medical transport services ... industry through the use of technology. Now, SmartEMS has put forth an industry-changing ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
Breaking Medicine Technology: